
By Marketwired . | Article Rating: |
|
November 7, 2012 03:00 PM EST | Reads: |
200 |

IRVINE, CA -- (Marketwire) -- 11/07/12 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Credit Suisse 2012 Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona on Wednesday, November 14, 2012.
Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer, is scheduled to speak to conference attendees at 10:30 a.m. MST (12:30 p.m. EST). A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
Media Contact:
Sarah Huoh
949-250-5070
Investor Contact:
David K. Erickson
949-250-6826
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
www.edwards.com
Published November 7, 2012 Reads 200
Copyright © 2012 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.
![]() Apr. 24, 2018 10:45 AM EDT Reads: 1,733 |
By Yeshim Deniz Apr. 24, 2018 10:30 AM EDT Reads: 1,110 |
By Yeshim Deniz ![]() Apr. 24, 2018 10:00 AM EDT Reads: 2,014 |
By Elizabeth White ![]() Apr. 24, 2018 10:00 AM EDT Reads: 2,088 |
By Yeshim Deniz Apr. 24, 2018 10:00 AM EDT Reads: 2,689 |
By Pat Romanski Apr. 24, 2018 09:45 AM EDT Reads: 2,336 |
By Liz McMillan Apr. 24, 2018 09:30 AM EDT Reads: 2,694 |
By Elizabeth White ![]() Apr. 24, 2018 09:30 AM EDT Reads: 6,579 |
By Yeshim Deniz Apr. 24, 2018 09:15 AM EDT Reads: 2,830 |
By Yeshim Deniz Apr. 24, 2018 08:30 AM EDT Reads: 1,143 |
By Elizabeth White ![]() Apr. 24, 2018 08:30 AM EDT Reads: 1,175 |
By Liz McMillan ![]() Apr. 24, 2018 08:15 AM EDT Reads: 5,634 |
By Liz McMillan ![]() Apr. 24, 2018 08:00 AM EDT Reads: 5,250 |
By Liz McMillan ![]() Apr. 24, 2018 07:30 AM EDT Reads: 3,967 |
By Liz McMillan ![]() Apr. 24, 2018 07:00 AM EDT Reads: 5,472 |